Abound Wealth Management

Position in GILD — Gilead Sciences, Inc.

CIK 1950323 FRANKLIN, TN

Position in GILD

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$7,959

-$19,636 QoQ

Shares Held

-68.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#2,194

of 2,266 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Abound Wealth Management holds $1,569,247 across 14 Drug Manufacturers - General names. GILD ranks #11 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	1,408	$354,309
2	AMGN	Amgen Inc	892	$323,011
3	LLY	ELI LILLY & Co	256	$307,054
4	MRK	Merck & Co., Inc.	1,649	$211,896
5	JNJ	Johnson & Johnson	630	$160,001
6	BMY	Bristol Myers Squibb Co	1,791	$103,197
7	AZN	Astrazeneca PLC	197	$37,355
8	PFE	Pfizer Inc	1,183	$28,486

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,959	63	-68.2%	Shares	Sole	2026-07-10
2026-03-31	$27,595	198	+11.2%	Shares	Sole	2026-04-10
2025-12-31	$21,847	178	+3.5%	Shares	Sole	2026-01-12
2025-09-30	$19,092	172	0.0%	Shares	Sole	2025-10-10
2025-06-30	$19,069	172	+17.8%	Shares	Sole	2025-07-14
2025-03-31	$16,359	146	-25.1%	Shares	Sole	2025-04-17
2024-12-31	$18,012	195	-46.6%	Shares	Sole	2025-01-13
2024-09-30	$30,601	365	+100.5%	Shares	Sole	2024-11-04
2024-06-30	$12,487	182	-12.1%	Shares	Sole	2024-08-09
2024-03-31	$15,162	207	-15.5%	Shares	Sole	2024-08-08
2023-12-31	$19,847	245	+22.5%	Shares	Sole	2024-08-08
2023-09-30	$14,988	200	+1.0%	Shares	Sole	2024-08-08
2023-06-30	$15,259	198	+18.6%	Shares	Sole	2024-08-08
2023-03-31	$13,855	167	+20.1%	Shares	Sole	2024-08-07
2022-12-31	$11,933	139	+43.3%	Shares	Sole	2024-08-07
2022-09-30	$5,983	97	—	Shares	Sole	2024-08-07
No filing history on record for this holder in this stock.